For instance, the measurement of mRNA levels indicated a reduced A2A receptor density in the caudate and putamen of patients with Parkinson’s disease (PD) [5], while increased A2A protein levels were found in PD patients with dyskinesias [6, 7] and in patients with Huntington’s disease (HD) [8]. Here, IGKV2D-29 is linked to Huntington disease.